相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis
Yu Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Yukio Hosomi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer
Hadi Ghasemi et al.
MOLECULAR BIOLOGY REPORTS (2020)
Reactive Oxygen Species Modulator I is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study
Moonkyoo Kong et al.
ONCOTARGETS AND THERAPY (2020)
Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer
Mohammad Amin Amini et al.
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Current Status of Immunotherapy for Lung Cancer and Future Perspectives
Ho Cheol Kim et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2020)
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Edward B. Garon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study
Moonkyoo Kong et al.
ONCOTARGETS AND THERAPY (2019)
Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Ho Cheol Kim et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2019)
Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
Eun Kyong Goag et al.
JOURNAL OF CANCER (2018)
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
In Ae Kim et al.
BMC CANCER (2018)
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
Tatsuya Nagano et al.
CELLS (2018)
ROS mediates interferon gamma induced phosphorylation of Src, through the Raf/ERK pathway, in MCF-7 human breast cancer cell line
Kazem Zibara et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2017)
Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines
Lu Zhang et al.
LUNG CANCER (2017)
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Seung Hyeun Lee et al.
CANCER RESEARCH AND TREATMENT (2017)
Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228
Lenora Ann Pluchino et al.
CANCER LETTERS (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study
Kaname Nosaki et al.
LUNG CANCER (2016)
Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
D. Zheng et al.
SCIENTIFIC REPORTS (2016)
Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Norikazu Matsuo et al.
SCIENTIFIC REPORTS (2016)
Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
Yoon Soo Chang et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2016)
Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion
Sora Lee et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
Imoh S. Okon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection
Seung Hyeun Lee et al.
LUNG CANCER (2015)
Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR
Eiji Iwama et al.
ONCOTARGET (2015)
Romo1 expression contributes to oxidative stress-induced death of lung epithelial cells
Jung Ar Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
Akito Hata et al.
CANCER (2013)
ROS-major mediators of extracellular matrix remodeling during tumor progression
Dragana Nikitovic et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
EMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Elisa Giannoni et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Overexpression of Romo1 Promotes Production of Reactive Oxygen Species and Invasiveness of Hepatic Tumor Cells
Jin Sil Chung et al.
GASTROENTEROLOGY (2012)
Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors
Simone Filosto et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Erlotinib-Mediated Inhibition of EGFR Signaling Induces Metabolic Oxidative Stress through NOX4
Kevin P. Orcutt et al.
CANCER RESEARCH (2011)
EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization
Simone Filosto et al.
PLOS ONE (2011)
Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
Juliann Chmielecki et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
Anamaria Brozovic et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Critical role for Romo1-derived ROS in cell proliferation
Ah Ram Na et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Drug resistance to 5-FU linked to reactive oxygen species modulator 1
In Tae Hwang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1
YA Yoo et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
分享论文
